ABBOTT LABORATORIES (1ABT.MI) Stock Price & Overview
BIT:1ABT • US0028241000
The current stock price of 1ABT.MI is 93.92 EUR. Today 1ABT.MI is down by -3.33%.
1ABT.MI Key Statistics
- Market Cap
- 163.203B
- P/E
- 21.06
- Fwd P/E
- 18.89
- EPS (TTM)
- 4.46
- Dividend Yield
- 2.27%
1ABT.MI Stock Performance
1ABT.MI Stock Chart
1ABT.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1ABT.MI.
1ABT.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 1ABT.MI. 1ABT.MI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
1ABT.MI Earnings
On January 22, 2026 1ABT.MI reported an EPS of 1.5 and a revenue of 11.46B. The company missed EPS expectations (-0.75% surprise) and missed revenue expectations (-3.88% surprise).
1ABT.MI Forecast & Estimates
35 analysts have analysed 1ABT.MI and the average price target is 114.43 EUR. This implies a price increase of 21.84% is expected in the next year compared to the current price of 93.92.
For the next year, analysts expect an EPS growth of 11.53% and a revenue growth 7% for 1ABT.MI
1ABT.MI Groups
Sector & Classification
1ABT.MI Financial Highlights
Over the last trailing twelve months 1ABT.MI reported a non-GAAP Earnings per Share(EPS) of 4.46. The EPS increased by 10.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.72% | ||
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| Debt/Equity | 0.19 |
1ABT.MI Ownership
1ABT.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 14.75 | 100.618B | ||
| SHL | SIEMENS HEALTHINEERS AG | 15.32 | 45.12B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 16.36 | 23.91B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 16.23 | 23.9B | ||
| BIM | BIOMERIEUX | 19.49 | 11.291B | ||
| DIA | DIASORIN SPA | 16.99 | 3.852B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 18.64 | 3.567B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.99 | 2.181B | ||
| DRW3 | DRAEGERWERK AG - PREF | 10.98 | 1.609B | ||
| DRW8 | DRAEGERWERK AG | 8.88 | 1.298B | ||
| ELN | EL.EN. SPA | 21.29 | 1.022B | ||
| EUZ | ECKERT & ZIEGLER SE | 18.21 | 953.435M | ||
| GVS | GVS SPA | 13.06 | 674.427M |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1ABT.MI
Company Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 115,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Company Info
IPO: 1937-03-01
ABBOTT LABORATORIES
100 Abbott Park Road, Abbot Park
ABBOTT PARK ILLINOIS US
Employees: 115000
Phone: 12246676100
ABBOTT LABORATORIES / 1ABT.MI FAQ
What does 1ABT do?
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 115,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
What is the current price of 1ABT stock?
The current stock price of 1ABT.MI is 93.92 EUR. The price decreased by -3.33% in the last trading session.
What is the dividend status of ABBOTT LABORATORIES?
ABBOTT LABORATORIES (1ABT.MI) has a dividend yield of 2.27%. The yearly dividend amount is currently 2.05.
What is the ChartMill technical and fundamental rating of 1ABT stock?
1ABT.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Where is ABBOTT LABORATORIES (1ABT.MI) stock traded?
1ABT.MI stock is listed on the Euronext Milan exchange.
How is the valuation of ABBOTT LABORATORIES (1ABT.MI) based on its PE ratio?
The PE ratio for ABBOTT LABORATORIES (1ABT.MI) is 21.06. This is based on the reported non-GAAP earnings per share of 4.46 and the current share price of 93.92 EUR.